Thorsten Hage

845 total citations
9 papers, 622 citations indexed

About

Thorsten Hage is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Thorsten Hage has authored 9 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Immunology. Recurrent topics in Thorsten Hage's work include Phosphodiesterase function and regulation (5 papers), Immune Response and Inflammation (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Thorsten Hage is often cited by papers focused on Phosphodiesterase function and regulation (5 papers), Immune Response and Inflammation (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Thorsten Hage collaborates with scholars based in Germany, Netherlands and United States. Thorsten Hage's co-authors include Walter Sebald, Peter Reinemer, Bojiang Shen, Ute Egerland, Nicholas J. Brandon, Michael S. Malamas, Barbara Langen, Karen L. Marquis, Radka Graf and Thomas A. Comery and has published in prestigious journals such as Cell, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Thorsten Hage

9 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thorsten Hage Germany 7 425 183 158 75 68 9 622
Paul Diaz United States 12 362 0.9× 31 0.2× 160 1.0× 192 2.6× 50 0.7× 17 775
Nadine Daniel France 8 373 0.9× 40 0.2× 171 1.1× 230 3.1× 40 0.6× 8 729
Anke Prinz Germany 14 588 1.4× 59 0.3× 28 0.2× 104 1.4× 61 0.9× 17 665
Thomas McAvoy United States 14 601 1.4× 39 0.2× 58 0.4× 176 2.3× 52 0.8× 19 822
Melvin E. Young United States 16 197 0.5× 47 0.3× 191 1.2× 54 0.7× 136 2.0× 18 515
Naj Sharif United States 13 261 0.6× 72 0.4× 35 0.2× 104 1.4× 16 0.2× 24 636
Mark W. Strohsacker United States 8 340 0.8× 38 0.2× 31 0.2× 152 2.0× 35 0.5× 9 498
Rajala V.S. Raju Canada 15 520 1.2× 55 0.3× 39 0.2× 47 0.6× 83 1.2× 26 604
Cuifen Hou United States 13 400 0.9× 41 0.2× 81 0.5× 126 1.7× 102 1.5× 23 586
Anna A. Rybczynska Netherlands 12 402 0.9× 34 0.2× 66 0.4× 136 1.8× 93 1.4× 20 566

Countries citing papers authored by Thorsten Hage

Since Specialization
Citations

This map shows the geographic impact of Thorsten Hage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Hage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Hage more than expected).

Fields of papers citing papers by Thorsten Hage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Hage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Hage. The network helps show where Thorsten Hage may publish in the future.

Co-authorship network of co-authors of Thorsten Hage

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Hage. A scholar is included among the top collaborators of Thorsten Hage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Hage. Thorsten Hage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Scherf, Nico, et al.. (2012). Phosphodiesterase 2 Inhibitors Promote Axonal Outgrowth in Organotypic Slice Co-Cultures. Neurosignals. 21(3-4). 197–212. 14 indexed citations
2.
Rutten, Kris, Eva Bollen, Thorsten Hage, et al.. (2012). Inhibition of phoshodiesterase type 2 or type 10 reverses object memory deficits induced by scopolamine or MK-801. Behavioural Brain Research. 236(1). 16–22. 73 indexed citations
3.
4.
Stange, Hans, Hans‐Joachim Lankau, Christian Grunwald, et al.. (2010). Discovery of Imidazo[1,5-a]pyrido[3,2-e]pyrazines as a New Class of Phosphodiesterase 10A Inhibitiors. Journal of Medicinal Chemistry. 53(11). 4399–4411. 50 indexed citations
5.
Grauer, Steven M., Virginia Pulito, Rachel L. Navarra, et al.. (2009). Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia. Journal of Pharmacology and Experimental Therapeutics. 331(2). 574–590. 223 indexed citations
6.
Hage, Thorsten, et al.. (2004). RNA-Based Drug Screening Using Automated RNA Purification and Real-time RT-PCR1. SLAS DISCOVERY. 9(2). 95–102. 3 indexed citations
7.
Hage, Thorsten, Walter Sebald, & Peter Reinemer. (1999). Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface. Cell. 97(2). 271–281. 174 indexed citations
8.
Hage, Thorsten, Peter Reinemer, & Walter Sebald. (1998). Crystals of a 1 : 1 complex between human interleukin‐4 and the extracellular domain of its receptor α chain. European Journal of Biochemistry. 258(2). 831–836. 7 indexed citations
9.
Shen, Bojiang, Thorsten Hage, & Walter Sebald. (1996). Global and Local Determinants for the Kinetics of Interleukin‐4/Interleukin‐4 Receptor α Chain Interaction. European Journal of Biochemistry. 240(1). 252–261. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026